Rituximab in non-systemic vasculitic neuropathy: a single-center experience.

Felix KohleGilbert WunderlichGereon R FinkMichael SchroeterHelmar C LehmannChristian Schneider

Published in: Journal of neurology (2024)

Anti-CD20 therapy might be an alternative in NSVN patients requiring further treatment escalation or treatment switch due to side effects of corticosteroids or cyclophosphamide.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
randomized controlled trial
peritoneal dialysis
clinical trial
diffuse large b cell lymphoma
prognostic factors
open label
mesenchymal stem cells
hodgkin lymphoma
study protocol
double blind